Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...
Arcutis is a rare topical dermatology player with accelerating launch metrics and continued growth. Read more about the ...
10d
TipRanks on MSNInnoCare Pharma Presents Promising Phase II Data for Psoriasis DrugInnoCare Pharma Ltd. ( ($HK:9969) ) just unveiled an update. InnoCare Pharma Ltd. announced the successful presentation of phase II clinical data ...
In a cohort of more than 11,000 patients from the U.K. and Ireland, a comparable proportion of new adalimumab users achieved ...
The onset of diabetes is most common in people ages 45 to 64. Type 2 diabetes is the most common form of diabetes. It usually appears after the age of 45 but can occur at any age. The development ...
Background: Obesity and dyslipidemia, major global health concerns, have been linked to psoriasis, but previous studies faced methodological limitations and their shared genetic basis remains unclear.
This fuels the excessive immune response typical of psoriasis. With the key role of SSAT in the inflammatory process, the researchers have simultaneously discovered a new starting point for therapy: ...
Hawaii is the most expensive state to buy a house, with a typical home value of $982,134, according to the Zillow Home Value Index average over the fourth quarter of 2024. West Virginia is the ...
Initiating methotrexate within 2 years of a psoriasis diagnosis is associated with a reduced risk of progressing to PsA.
Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results